Kaival Brands Innovations Group Inc (KAVL) Stock Analysis

$0.136

-0.017 (-12.26%)At close

Loading chart…

High: 0.155
Open: 0.150
VWAP: 0.14
Vol: 35.30M
Mkt Cap: 7.38M
Low: 0.116
Amount: 4.78M
EV/EBITDA, TTM: 0.00

Kaival Brands Innovations Group, Inc. is engaged in the sale, marketing and distribution of electronic nicotine delivery system (ENDS) products, also known as e-cigarettes, in a variety of favors. The Company operates through an international licensing agreement with Philip Morris Products S.A. (PMPSA), a wholly owned affiliate of Philip Morris International Inc. (PMI). Its patent portfolio consists of approximately 19 existing and 47 pending with technologies related to vaporization and inhalation technologies. Its trademarks include KAIVAL BRANDS and KAIVAL LABS.

kaivalbrands.com

Valuation Metrics

The current forward P/E ratio for Kaival Brands Innovations Group Inc (KAVL) is -0.08, compared to its 5-year average forward P/E of -28.34.

Forward P/E

Fair

5Y Average P/E

-28.34

Current P/E

-0.08

Overvalued

43.47

Undervalued

-100.14

Forward EV/EBITDA

Strongly Undervalued

5Y Average EV/EBITDA

0.00

Current EV/EBITDA

0.00

Overvalued

0.00

Undervalued

0.00

Forward P/S

Fair

5Y Average P/S

1.06

Current P/S

0.00

Overvalued

2.27

Undervalued

-0.15

Events Timeline

2025-01-10 (ET)

07:34:54

Kaival Brands, Delta Corp announce public filing of registration statement

2024-09-30 (ET)

08:42:55

Kaival, Delta Corp announce confidential submission of registration statement

2024-09-23 (ET)

09:14:50

Kaival Brands enters merger, share exchange agreement with Delta Corp

Show More Events

News

KAVL FAQ — answered by Alphio AI

Kaival Brands Innovations Group, Inc. is engaged in the sale, marketing and distribution of electronic nicotine delivery system (ENDS) products, also known as e-cigarettes, in a variety of favors. The Company operates through an international licensing agreement with Philip Morris Products S.A. (PMPSA), a wholly owned affiliate of Philip Morris International Inc. (PMI). Its patent portfolio consists of approximately 19 existing and 47 pending with technologies related to vaporization and inhalation technologies. Its trademarks include KAIVAL BRANDS and KAIVAL LABS. It operates in the Consumer Non-Cyclicals sector (RETAIL-NONSTORE RETAILERS industry).

This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.